AI in Medicine - curated summaries making complex issues easy to understand
Company Spotlight: Median Technologies eyonis LCS - Risk Stratifying Lung Cancer Screening
· 13 min
Notas do episódio
In this Company Spotlight, we dive into the FDA 510(k) clearance for Median Technologies' eyonis LCS 1.1. We unpack how this AI tool aims to go beyond basic nodule detection by assigning malignancy risk scores on low-dose chest CTs, and what the reader study numbers reveal about false positives in clinical practice.
Key points
• Median Technologies received FDA clearance for eyonis LCS 1.1, an AI software that detects, localizes, and characterizes pulmonary nodules on low-dose Chest CT images.
• The software assigns a 10-point score to solid and part-solid nodules between 4-30 mm, while…
Site: ai-in-medicine-podcast.vercel.app
